Advocacy intelligence hub — real-time data for patient organizations
Jaeb Center for Health Research
Simulect: FDA approved
Prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Simulect
Novartis Pharmaceuticals Corporation
Thomas MS Wolever, MD, PhD
President, Medical Director
Todd Durham, PhD
Senior Vice President, Clinical and Outcomes Research
Jeffrey B Blumberg, PhD, MD
Tufts Medical Center
📍 CHAPEL HILL, NC
John L Sievenpiper, PhD, MD
University of Toronto
Mandeep S. Singh
John Hopkin's - Wilmer Eye Institute